drug-eluting balloons

Tips and Techniques

The Evolving Field of Local Drug Delivery for Superficial Femoral Artery Intervention

05/05/2017

Juan F. Granada, MD

CRF-Skirball Center for Innovation, Cardiovascular Research Foundation, Columbia University Medical Center, New York

Juan F. Granada, MD CRF-Skirball ...

Local drug delivery is rapidly emerging as the first line of therapy for the interventional treatment of superficial femoral artery disease. Paclitaxel-eluting drug-coated balloons are emerging as a promising therapy.

Local drug delivery is rapidly...

05/05/2017

Vascular Disease Management

Preliminary Results From the DRASTICO Trial: A Discussion With Francesco Liistro, MD

02/09/2017

Jennifer Ford

An interview with the principal investigator of the ongoing DRASTICO trial, which is comparing drug-eluting stent vs drug-eluting balloon in complex patients.

An interview with the principal...

02/09/2017

Vascular Disease Management

Interview

Preliminary Results From the DRASTICO Trial: A Discussion With Francesco Liistro, MD

02/09/2017

An interview with the principal investigator of the ongoing DRASTICO trial, which is comparing drug-eluting stent vs drug-eluting balloon in complex patients.

An interview with the principal...

02/09/2017

Vascular Disease Management

Peter Schneider, MD, Shares 1-Year Results From the IN.PACT SFA I and II Trials

03/27/2015

Peter Schneider, MD, describes results from the European and US arms of the IN.PACT SFA trial, which evaluated safety and efficacy of the In.Pact Admiral drug-eluting balloon compared to plain balloon angioplasty in the superficial femoral...

Peter Schneider, MD, describes...

03/27/2015

Vascular Disease Management

Thomas Zeller, MD, Discusses Failure of DEB to Show Benefit in IN.PACT DEEP

03/27/2015

The multicenter randomized controlled IN.PACT DEEP trial compared paclitaxel-coated balloons with uncoated balloons and failed to show benefit for the drug-eluting balloon.

The multicenter randomized...

03/27/2015

Vascular Disease Management

Andrej Schmidt, MD, Describes Benefits of Drug-Eluting Balloons for Infrapopliteal Lesions

03/03/2015

Dr. Andrej Schmidt, MD, senior interventionalist at the University Clinic of Leipzig in Germany, discusses results from a single-center study using paclitaxel-coated drug-eluting balloons for infrapopliteal lesions.

Dr. Andrej Schmidt, MD, senior...

03/03/2015

Vascular Disease Management

Early Clinical Results for Drug-Eluting Balloons

03/03/2015

Drug-eluting balloon therapy is poised to improve patency of interventional therapy of superficial femoral and popliteal arterial obstructions.

Drug-eluting balloon therapy is...

03/03/2015

Vascular Disease Management

Early Clinical Results for Drug-Eluting Balloons

03/03/2015

Drug-eluting balloon therapy is poised to improve patency of interventional therapy of superficial femoral and popliteal arterial obstructions.

Drug-eluting balloon therapy is...

03/03/2015

Vascular Disease Management

Erik E. Debing, MD, PhD, Discusses the IN.PACT Belgian Diabetic Drug-Coated Balloon Trial

01/26/2015

At the 41st annual VEITHSymposium, Erik E. Debing, MD, PhD, presented mid-term results from the Belgian IN.PACT trial. Vascular Disease Management asked Dr. Debing to share details about the results.

At the 41st annual...

01/26/2015

Vascular Disease Management

Gunnar Tepe, MD, Discusses the BIOLUX P-III Study

01/01/2015

Vascular Disease Management spoke about the BIOLUX P-III study with clinical investigator Gunnar Tepe, MD, head of the Institute of Diagnostic and Interventional Radiology at RoMed Clinic Rosenheim in Germany.

Vascular Disease Management...

01/01/2015

Vascular Disease Management